Arcturus Therapeutics Holdings Inc.
ARCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -30% | -16.6% | 39.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 80.5% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -74% | -44.2% | -54.5% | -139% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -78.4% | -37.5% | -47.9% | -142.9% |
| EPS Diluted | -0.49 | -0.34 | -0.52 | -1.11 |
| % Growth | -44.1% | 34.6% | 53.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |